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Abstract
Oxygen metabolismisa strongpredictor ofthegeneralhealthand fitnessofanorganism.Inthisstudy,wehypothesizedthata
divergence in intrinsic aerobic fitness would co-segregate with susceptibility for cardiovascular dysfunction. To test this
hypothesis, cardiac function was assessed in rats specifically selected over nineteen generations for their low (LCR) and high
(HCR) intrinsic aerobic running capacity. As an integrative marker of native aerobic capacity, run time to exhaustion between
LCR and HCR rats had markedly diverged by 436% at generation nineteen of artificial selection. In vivo assessment of baseline
cardiac function by echocardiography and catheter-based conductance micromanometry showed no marked difference in
cardiac performance. However, when challenged by exposure to acute hypoxia, cardiac pump failure occurred significantly
earlier in LCR rats compared to HCR animals. Acute cardiac decompensation in LCR rats was exclusively due to the
development of intractable irregular ventricular contractions. Analysis of isolated cardiac myocytes showed significantly
slower sarcomeric relaxation and delayed kinetics of calcium cycling in LCR myocytes compared to HCR myocytes. This study
also revealed that artificial selection for low native aerobic capacity is a novel pathologic stimulus that results in myosin heavy
chain isoform switching in the heart as shown by increased levels of b-MHC in LCR rats. Together, these results provide
evidence that alterations in sub-cellular calcium handling and MHC isoform composition are associated with susceptibility to
compensatory cardiac remodeling and hypoxia induced pump failure in animals with low intrinsic aerobic capacity.
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Introduction
The prevalence of metabolic syndrome has come to be regarded
as a window into the general health of a population [1]. Aspects of
metabolic syndrome associated with cardiovascular disease include
abdominal obesity, atherogenic dyslipidemia, elevated blood
pressure, insulin resistance with or without glucose intolerance, a
pro-inflammatory state, and a pro-thrombotic state [2]. Studies in
the U.S. have shown that nearly a quarter of the population (an
estimated 47 million people) have metabolic syndrome [3].
Previous studies of mono and dizygotic twins have shown that
about 70% of the variation in aerobic capacity is due to
inheritance [4]. Furthermore, cross-sectional and prospective
studies have found that levels of physical activity and fitness are
inversely related to the prevalence of metabolic syndrome [5].
These and other studies suggest a link between intrinsic aerobic
capacity, based on genetic and environmental influences, and
complex disease states [5,6,7,8,9].
Clinically relevant research models for metabolic syndrome
must take into account the interaction between individual
polygenic traits and environmental influences. In recent years,
one such model has emerged providing a means to scientifically
dissect complicated interactions at all levels of biological
organization. As illustrated in previous studies, we have generated
a unique breeding scheme based on inherent aerobic running
capacity that has resulted in a significant divergence in native
running capacity between two populations, termed low capacity
runners (LCR) and high capacity runners (HCR) [10,11,12].
Previous reports on these rats have shown a significant
divergence in risk factors associated with metabolic syndrome
that align with selection for low versus high intrinsic aerobic
exercise capacity. More specifically, risk factors associated with
cardiovascular dysfunction have markedly diverged with aerobic
capacity including cardiac energy substrate utilization [13],
expression of key mitochondrial proteins [12], oxygen transport
[14,15,16], and susceptibility to cardiac arrhythmias [17].
In light of our current level of knowledge about this animal
model, several important questions remain. First, catheter-based
conductance micromanometric analysis of cardiac hemodynamics
has not been performed on this animal model. This methodology
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cardiac pump performance of LCR and HCR rats at baseline,
during catecholaminergic manipulation, and in response to an
acute hypoxic stress. Furthermore, in vitro analysis of myocyte
calcium handling, contractile kinetics, and biochemical analysis of
protein post-translational modifications provide a sub-cellular
perspective into a molecular and cellular basis for pathologies
observed in vivo. Specific markers of heart failure such as activation
of the fetal gene program (e.g. MHC isoform switching) and
correlative alterations in thyroid hormone function also have not
been assessed in this model of metabolic syndrome. We
hypothesized that data derived from these cell and molecular
assays would provide important mechanistic insights into the
underlying cardiovascular pathologies observed within this disease
model.
Rats used in this study were derived from 19 generations of
selection correlating with a 436% divergence in intrinsic aerobic
running capacity. Based on this divergence in inherent aerobic
fitness and previous evidence of diverging susceptibilities for
cardiovascular risk factors between LCR and HCR rats
[12,17,18,19], we hypothesized that indexes of cardiac function
would co-segregate with intrinsic aerobic capacity. This focused
analysis on the heart provides insights into the complex
pathophysiology associated with metabolic syndrome and supports
the hypothesis that low intrinsic aerobic capacity portends an
increased susceptibility to cardiac dysfunction during cardiac
stresses such as oxygen deprivation.
Methods
Animal model
Adult rats selectively bred for their inherent high capacity
(HCR) or low capacity (LCR) endurance treadmill running, as
previously outlined [12], were used for this study. All animals were
given food and water ad libitum. The procedures used in this study
are in agreement with the guidelines of the University of Michigan
and approved by the University of Michigan Committee on the
Use and Care of Animals.
Conductance Micromanometry
Real-time measurements of in vivo cardiovascular hemodynam-
ics were obtained using conductance micromanometry as
previously performed [20]. Rats were anesthetized and ventilated
via a tracheal cannulation and ventilated via a pressure controlled
ventilator with 1% isoflurane at a peak inspiratory pressure of
15 cm H2O and a respiratory rate of 60 breaths/min. An
arteriotomy was then performed on the right carotid artery
followed by insertion of a 2.0 French Millar pressure-volume
catheter (SPR-838; Millar Instruments Inc., Houston, Texas,
USA). The catheter was subsequently advanced into the junction
of the carotid artery and aorta at which point arterial pressure
analysis was performed. The catheter was then advanced further
into the left ventricle for cardiac hemodynamic analysis. Pressure-
volume loops were collected on line at 1 kHz. Data were analyzed
with Biobench and PVAN software. Pancuronium bromide was
administered IP to block spontaneous respiratory muscle activity
(0.4 mg/kg). After obtaining baseline hemodynamics (ventilated
with isoflurane and O2), rats received a continuous infusion of
esmolol (250 ug/kg/min) for five minutes. After returning to
baseline hemodynamics, rats were then infused with dobutamine
(42 ug/kg/min) for two minutes. After returning to baseline, rats
were subjected to a long term hypoxia challenge (ventilation with
7% oxygen balanced with nitrogen). For each experimental
animal, cardiac function was assessed for all manipulations
described above. All hemodynamic values reported in this study
were derived during ventilation with 100% oxygen (baseline,
dobutamine, and esmolol) or during exposure to 7% oxygen
(hypoxia). Isoflurane is known to have a cardioprotective effect
which may have attenuated the severity of the hypoxia challenge
on these animals [21]. Even so, equal exposure to animals in this
study makes comparative analysis of cardiac performance during
this challenge informative to our understanding of energy
metabolism and cardiovascular function in the context of
metabolic disease.
Using the LV pressure waveform as a marker of cardiac
contraction, data were acquired during hypoxia until either
sustained irregular ventricular contractions or acute systolic pump
failure occurred. Irregular contractions were defined by calculat-
ing R–R intervals. Irregular contractile events were defined as
positive or negative deflections of at least 15 msec away from the
baseline intervals. Baseline was defined as the mean value over 50
beats before or after a given period excluding those beats identified
as irregular, as follows. Close scrutiny of R–R intervals revealed
patterns of intractable irregular contractions used to demarcate
termination of the experiment in certain animals. These criteria
include: greater than 2 R–R intervals of 200 ms or more above
baseline within 20 beats, greater than 15 R–R intervals of 25 ms
or more above baseline within 20 beats, and greater than 30 R–R
intervals of 120 ms or more above baseline within 100 beats.
Acute cardiac failure due to pump dysfunction was defined as LV
pressure reaching 60% of initial peak systolic pressure. Whether
acute pump failure was determined to be caused by irregular
ventricular contractions or pump dysfunction, rats were immedi-
ately recovered using 100% O2 in order to obtain measurements
for instrument calibration. All pressure waveform data was used to
assess irregular beat intervals using programs and macros derived
from LabVIEW and Microsoft Excel.
Echocardiography
Anesthesia was induced with 3% isoflurane and then main-
tained at 1% for the duration of the procedure. Transthoracic
echocardiography was performed in the supine or left lateral
position. Two-dimensional, M-mode, Doppler and tissue Doppler
echocardiographic images were recorded using a Visual Sonics’
Vevo 770 high resolution in vivo micro-imaging system. We
measured systolic and diastolic dimensions and wall thickness in
M-mode in the parasternal short axis view at the level of the
papillary muscles. Fractional shortening and ejection fraction were
calculated from the M-mode parasternal short axis view. We
assessed diastolic function by conventional pulsed-wave spectral
Doppler analysis of mitral valve inflow patterns (early [E] and late
[A] filling waves). Doppler tissue imaging (DTI) was used to
measure the early (Ea) and late (Aa) diastolic tissue velocities of the
lateral annulus. Rats were assessed for baseline cardiac function
while being ventilated with 100% oxygen.
Ventricular myocyte isolation and primary culture
LCR and HCR rats were anaesthetized by inhalation of
isoflurane followed by i.p. injection of heparin (1500 U/kg) and
Nembutal (162.5 U/kg). Following enzymatic digestion by retro-
grade perfusion with collagenase and hyaluronidase and gentle
mincing of the cardiac ventricles, cardiac myocytes were plated on
laminin-coated glass coverslips (2610
4 myocytes/coverslip) and
cultured in M199 media (Sigma, supplemented with 10 mmol/L
glutathione, 26.2 mmol/L sodium bicarbonate, 0.02% bovine
serum albumin, and 50 U/ml penicillin-streptomycin, with pH
adjusted to 7.4, as described previously [22]).
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myocytes
Myocytes were loaded with fura-2AM (a ratiometric calcium
indicator, 2 mmol/L) for 10 minutes at room temperature. Following
a de-esterification period of 20 min in M199 media (1.8 mmol/L
Ca2+), loaded cells were placed on the inverted microscope (Nikon,
Eclipse TE2000) and stimulated at 0.2 Hz. The chamber’s
temperature was maintained at 37uC. Fura-2 fluorescence was
measured using an IonOptix spectrophotometer (Stepper Switch).
Initially, fura was excited by 360 nm (the Fura isosbestic point, a
calcium independent measure of fura fluorescence) light and then
continuously with 380 nm (calcium dependent measure of fura
fluorescence) light. Emitted fura fluorescence was collected by the
406 objective, passed through a 510 nm filter and detected by a
photomultiplier tube. Ratiometric data was collected and analyzed
online using commercial software (IonOptix Corp.). Together with
calcium measurements, cell contractility was also measured. Myocyte
images were collected (240 Hz) using a CCD camera (MyoCam,
IonOptix). Myocytes that did not follow the pacing protocol (0.2 Hz)
were excluded, as were myocytes with a resting sarcomere length less
than 1.75 mm. Velocity of shortening was measured in these
electrically paced myocytes. Velocity of shortening was calculated
using IonOptix software, which calculates the maximum of the first
derivative of the contraction transient during the shortening phase.
Likewise, the velocity of re-lengthening was measured as the
maximum of the first derivative of the re-lengthening phase.
Immunoblot detection
Hearts were isolated, snap frozen in liquid nitrogen, homoge-
nized and placed in Laemmli sample buffer. Proteins were
separated by SDS-PAGE and transferred to a nitrocellulose
membrane for immunodetection. After blocking in 5% milk (in
Tris-buffered saline), membranes were probed with specific
antibodiesdirected against b-myosinheavychain(ATCC), troponin
I phosphorylation at serine 23/24 (Cell Signaling Technology),
SERCA2a (Chemicon), phospholamban (Upstate), phospho-phos-
pholamban (Upstate), calsequestrin (ABR), and the sarcolemmal
sodium-calcium exchanger (Swant). Protein detection for actin was
used for loading control. Indirect immunodetection was carried out
using a fluorescently labeled secondary antibody (Rockland, IRDye
680 conjugated affinity purified; 1:5000). Western blot analysis was
accomplished using the infrared imaging system, Odyssey (Li-Cor,
Inc.) and images analyzed using Odyssey software v. 1.2.
Thyroid hormone analysis
Total serum was extracted from mice immediately after
decapitation. Samples were submitted for thyroid hormone panel
analysis at the University of Michigan hospital chemistry lab.
Quantitative RT-PCR
Total RNA was extracted from ventricles of LCR and HCR rats
using Trizol reagent (Invitrogen) according to the manufacture’s
instructions. Quality of total RNA was visualized via electropho-
resis on a 1.0% agarose gel. cDNA was generated from 1 mg RNA
by reverse transcriptase reaction using TaqMan RT reagent kit
(Applied Biosystems, Foster City, CA). All RT reactions to
generate cDNA were performed on the MJ Research PTC-200
thermocycler (Global Medical Instrumentation, Inc). Real-time
quantitative PCR was performed on cDNAs using the 2x SYBR
Green universal PCR master mix Kit (Applied Biosystems, Foster
City, CA) and run on Realplex
2 master cycler epgradient
(Eppendorf). All qPCR assays were performed in duplicate on
12 LCR and 12 HCR rats and normalized against wild type rat.
Cycling conditions consisted of one cycle of 95uC for 10 min, and
then 40 cycles of 95uC for 15 s followed by 60uC for 1 min. The
representative normalized average expression values from inde-
pendent experiments are shown for each gene.
Relative quantitative analysis of gene expression was conducted
according to the 2
2DDCT method. 18s rRNA was used as
endogenous internal standards for gene expression analysis to
determine the abundance of amplified target gene within the same
sample. Primers were designed using Primer select (DNAstar
lasergene 7). The amplification efficiency for all primers was in the
range of 90 to 100% as determined by standard curve. All primers
displayed single melting curve.
The following primers were used for RT-PCR:
Rat ANF-foward- TGAAAAGCAAACTGAGGGCT
Rat ANF-reverse- CTCCAGGAGGGTATTCACCA
Rat BNP- foward - CAGCTCTCAAAGGACCAAGG
Rat BNP- reverse AGAGCTGGGGAAAGAAGAGC
Rat aSKactin- foward - GCATGCAGAAGGAGATCACA
Rat aSKactin- reverse - CATAGCACGATGGTCGATTG
Rat bMHC- foward - AGATCGAGGACCTGATGGTG
Rat bMHC- reverse - GATGCTCTTCCCAGTTGAGC
Rat 18s rRNA- foward -TTTGTTGGTTTTCGGAACT-
GAGGC
Rat 18s rRNA- reverse -GGCATCGTTTATGGTCGGAAC-
TACG
Statistics
All results are expressed as mean6SEM. All two-group
comparisons were assessed by two-tailed t-test. All multi-group
comparisons were assessed using two way analysis of variance
(ANOVA) with Tukey post-hoc test. Survival during acute hypoxia
was assessed by the Fisher exact test.
Results
Analysis of intrinsic aerobic running capacity
Determination of intrinsic (non-trained) aerobic running
capacity was derived by a treadmill exercise test [12]. The single
best daily run of five trials for each rat was considered the trial
most closely associated with the animal’s heritable component of
exercise endurance. The founder population (generation 0) had a
capacity to run for 3556144 m (23.1 min) until exhausted.
Previous studies have reported that the treadmill-running capacity
for LCR rats decreased 16 m per generation and increased in
HCR rats by 41 m per generation in response to artificial selection
[12]. At generation 11, the LCRs averaged 191670 m (run time:
14.3 min), and the HCRs ran for 8536315 m (run time:
41.6 min). By comparison, the current study used rats selected
for 19 generations which showed further divergence in native
aerobic running capacity between LCR and HCR rats. Specifi-
cally, there were significant differences revealed in measures of
best distance run ([LCR] 217.066.3 vs. [HCR] 1813.7630.7
meters, P,0.05), best time ([LCR] 16.060.4 vs. [HCR] 68.260.7
minutes, P,0.05), and best speed ([LCR] 17.660.2 vs. [HCR]
43.660.4 meters/minute, P,0.05) (Figure 1a–c). These differenc-
es in intrinsic aerobic running performance prompted further
investigation into possible underlying variations in cardiovascular
function between LCR and HCR rats.
Cardiac function assessed by echocardiography
Assessment of baseline cardiac systolic and diastolic function as
well as cardiac LV geometry was performed by echocardiography.
Overall, these data showed minor differences in heart performance
Cardiac Failure of LCR Animals
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measures of cardiovascular systolic and diastolic function and LV
geometry were not different between groups (e.g. fractional
shortening (FS), cardiac output (CO), isovolumic relaxation time
(IVRT), and LV wall thickness) (Figure 2a and b, Table 1). Left
ventricular geometrical measures, however, showed a significantly
larger ventricular diastolic dimension in LCRrats compared to HCR
rats (LVDd [LCR] 9.160.2 vs. [HCR] 8.260.3 mm, P,0.05).
Gross heart and body weight analysis revealed that LCR rats
had significantly larger hearts by mass correlating with a
significantly larger body weight (Table 2). However, when
normalized for body weight, LCR rats had a significantly smaller
heart size compared to HCR rats (HW/BW ratio [LCR] 2.660.2
(610
23) vs. [HCR] 3.160.1 (610
23), P,0.05).
Cardiac function assessed by real-time conductance
micromanometry
To more precisely analyze cardiac pump performance in vivo,
rats were instrumented with a Millar pressure-conductance
catheter in the left ventricle. To measure the full range of cardiac
function, LCR and HCR rats were also treated to maximally
activate or inhibit beta adrenergic signaling. Measures of systolic
function (e.g. ejection fraction), and diastolic function (e.g. end
diastolic pressure (EDp), and LV pressure Tau) were not different
between low and high capacity rats (Figure 3a and b and Table 3).
Consistent with a higher end diastolic dimension as determined by
echocardiography, there was increased stroke volume among low
capacity animals at baseline ([LCR] 90.167.2 vs. [HCR]
72.463.7 uL, P,0.05).
Next, during dobutamine infusion to maximally stimulate the
adrenergic response in the heart, LCR and HCR rats showed
similar inotropic responsiveness based on significant increases in
the ejection fraction (EF) and maximal positive pressure derivative
(+dP/dt) (Figure 3 and Table 3). However, during dobutamine
infusion, LCR rats continued to maintain a significantly higher
stroke volume compared to HCR rats ([LCR] 110.2611.6 vs.
[HCR] 75.466.9 uL, P,0.05). Other measures of systolic and
diastolic function were not different during dobutamine infusion.
Figure 1. Intrinsic aerobic running capacity of LCR and HCR rats. Mean values derived from a treadmill run assessing aerobic running
capacity showing best distance run (a), best time (b), and best running speed (c) (n=14/group). Values are expressed as mean6SEM. *P,0.05. HCR,
high capacity runner, LCR, low capacity runner.
doi:10.1371/journal.pone.0006117.g001
Figure 2. Analysis of baseline cardiovascular function by echocardiography. (a) Echocardiographic images showing systolic and diastolic
dimensions (arrows) and wall thickness measured by M-mode in the parasternal short axis view at the level of the papillary muscles (left) as well as
diastolic function assessed by conventional pulsed-wave spectral Doppler analysis of mitral valve inflow patterns (early [E] and late [A] filling waves)
(right). (b) Summarized mean echo data of stroke volume, diastolic dimension, and fractional shortening. Values are expressed as mean6SEM.
*P,0.05. HCR, high capacity runner (n=6); LCR, low capacity runner (n=5).
doi:10.1371/journal.pone.0006117.g002
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no differences in cardiovascular performance were observed
between LCR and HCR rats (Figure 3 and Table 3). Analysis of
the delta response to dobutamine and esmolol as surrogate
markers of cardiac reserve and adrenergic tone, respectively,
showed no differences between groups (data not shown).
Systemic arterial pressures were analyzed by micromanometry
in the right carotid artery. Based on analysis of systolic, diastolic
and mean pressure measurements, these data showed that HCR
and LCR rats had no statistically significant difference in mean
Table 2. Heart and Body Weight Analysis.
HCR LCR
Heart Weight (g) 1.2760.0 1.4660.1*
Body Weight (g) 416.8614.5 570.3623.7*
HW/BW ratio (610
23) 3.160.1 2.660.2*
All values are expressed as mean6s.e.m.
*P,0.05.
HCR, high capacity runner (n=11); LCR, low capacity runner (n=12).
doi:10.1371/journal.pone.0006117.t002
Table 1. Baseline Function by Echocardiography.
Parameter HCR LCR
HR (bpm) 359.3615.7 323.5616.9
PW d (mm) 1.660.1 1.760.0
MV E (mm/s) 1270.8696.4 1142.36113.4
E/A 1.160.1 1.160.1
IVRT (ms) 20.661.9 22.563.3
TEI Index 0.3560.0 0.3660.0
E/Ela 37.864.7 35.469.2
LVDs (mm) 4.960.5 5.760.4
Echocardiographic parameters: heart rate (HR), LV posterior wall at diastole (PW
d), fractional shortening (FS), flow velocity of the mitral valve E wave (MV E),
flow velocities of the mitral valve E and A waves expressed as a ratio (E/A),
isovolumic relaxation time (IVRT), TEI index, the flow velocity of the mitral valve
E wave to the tissue velocity of the lateral annular E wave ratio (E/Ela), and LV
dimension during diastole (LVDd) and systole (LVDs). All values are expressed as
mean6s.e.m.
*P,0.05.
HCR, high capacity runner (n=6), LCR, low capacity runner (n=5).
doi:10.1371/journal.pone.0006117.t001
Figure 3. (a) Representative raw traces derived by conductance micromanometry of LV pressure (top; bar=60 mmHg), derivatives (middle;
bar=10,000 mmHg/sec), and volume (bottom; bar=50 uL) at baseline in LCR and HCR rats (time scale=0.4 sec). (b) Summarized mean data for
ejection fraction (EF) and stroke volume (SV) at baseline, during dobutamine infusion, and during esmolol infusion (n=4–9/group for all
hemodynamic data). (c) Raw traces of arterial blood pressure acquired by micromanometry measurements from the carotid artery and table of mean
blood pressure values for LCR and HCR rats (pressure scale=25 mmHg, time scale=1 sec) (n=9/group). Values are expressed as mean6SEM.
*P,0.05. HCR, high capacity runner, LCR, low capacity runner.
doi:10.1371/journal.pone.0006117.g003
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(Figure 3c and Table 3).
Cardiac function assessed during acute exposure to
hypoxia
The hypothesis was tested that differences in heritable oxygen
carrying capacity [23] would result in diverging cardiac responses
between LCR and HCR animals duringan acute hypoxic challenge
in vivo. To assess this, LCR and HCR rats were exposed to hypoxia
(ventilation with 7% oxygen) and assessed for cardiac function and
survival with real-time in vivo conductance micromanometry
analysis (Figure 4, Table 3). Results revealed significant differences
in cardiac responsiveness to hypoxic stress that segregated with
intrinsic running capacity. During hypoxia, rats with low intrinsic
exercise capacity (LCR) underwent acute cardiac pump failure
more rapidly than rats with high intrinsic exercise capacity (HCR)
(acute cardiac failure curve, P=0.02) (Figure 4).
The underlying etiology of cardiac pump failure was further
analyzed to determine the mechanism of decompensation
observed in HCR and LCR animals during this acute hypoxic
challenge. Specifically, contractile failure was defined as systolic
pump failure or the occurrence of defined patterns (see Methods)
of intractable irregular ventricular contractions. Analysis of the
cause of acute cardiac decompensation revealed that low capacity
runners (LCR) experienced sustained irregular ventricular con-
tractions without a marked diminution in LV pressure specifically
attributable to systolic performance (Figure 4a and 5). Since
electrocardiographic (ECG) analysis was not performed in parallel,
no conclusions are made here regarding the specific etiology of
these irregular beats based on the current data set. Analysis of the
periodicity of ventricular pressure traces showed a significantly
higher cumulative number of irregular beats in low capacity
runners than high capacity runners during the time course of
exposure to an acute hypoxic challenge (P,0.05) (Figure 5a and
b). Analysis of survival based on cardiac decompensation due
exclusively to fatal sustained irregular ventricular contractions
accentuates the propensity for cardiac pump failure among LCR
rats compared to HCR rats (P,0.05) (Figure 5c). Thus, HCR rats
survived significantly longer during the hypoxic challenge. Cardiac
pump failure of HCR rats was exclusively characterized as a
diminution in cardiac systolic performance during hypoxia with no
failures attributable to the development of fatal irregular
contractions (Figure 5c).
Functional analysis of LCR and HCR isolated cardiac
myocytes
We hypothesized that the basis of LCR heart susceptibility to
this hypoxic challenge resides in a functional contractile defect at
the single myocyte level. To test this, cardiac myocytes were
isolated from adult LCR and HCR rats and assessed for
contractile properties. Calcium handling was also measured using
the calcium indicator dye, fura-2AM. Interestingly, kinetics of the
calcium transient revealed that LCR myocytes had significantly
reduced calcium transient amplitudes ([LCR] 0.14260.011 vs.
[HCR] 0.20460.016 (360/380 ratio), P,0.05) and slower kinetics
of calcium decay compared to HCR myocytes (time from peak to
90% decay: [LCR] 572.7638.1 vs. [HCR] 458.4627.6 ms,
P,0.05) (Figure 6a and d). Contractile function was also assessed
by analysis of sarcomere length kinetics. Compared to myocytes
derived from HCR hearts, LCR myocytes had significantly shorter
resting sarcomere lengths and slower kinetics of contraction (time
to peak: [LCR] 166.064.9 vs. [HCR] 141.463.3 ms, P,0.05)
and relaxation (time from peak to 90% relaxation: [LCR]
Table 3. Real-time Hemodynamic Function.
Parameter HCR LCR
Baseline
HR (bpm) 378.8612.6 388.6610.7
ESp (mmHg) 135.664.4 133.065.0
EDp (mmHg) 13.761.1 14.460.9
CO (uL/min) 28, 88462,684 35,00462,945
SV (uL/beat) 72.463.6 90.167.2*
+dP/dt (mmHg/s) 11,6356726 12,1886639
2dP/dt (mmHg/s) 210,5066457 210,6496870
Tau w (msec) 10.660.4 10.560.5
Dobutamine
HR (bpm) 455.0612.6 448.0621.1
ESp (mmHg) 123.369.8 129.4611.7
EDp (mmHg) 9.361.2 8.261.0
CO (uL/min) 38089.864867 49916.266546
SV (uL/beat) 75.466.9 110.2611.6*
+dP/dt (mmHg/s) 20,10661,065 18,72661,758
2dP/dt (mmHg/s) 210,57661,233 210,59161,533
Tau w (msec) 8.460.4 7.660.3
Esmolol
HR (bpm) 340.5636.9 316.5614.5
ESp (mmHg) 109.0615.3 105.0623.6
EDp (mmHg) 3.860.9 3.461.5
CO (uL/min) 19537.564949 28658.066099
SV (uL/beat) 58.1615.1 88.9614.6
+dP/dt (mmHg/s) 7,2376880 7,54461,165
2dP/dt (mmHg/s) 27,6806891 28,09261,805
Tau w (msec) 10.760.6 10.060.2
Hypoxia
HR (bpm) 438.7616.5 449.2635.2
ESp (mmHg) 116.7613.6 137.0614.1
EDp (mmHg) 16.261.2 18.861.8
CO (uL/min) 32185.762005 53030.2610051
SV (uL/beat) 73.166.3 118.0620.5*
+dP/dt (mmHg/s) 11,77263,060 14,57161,714
2dP/dt (mmHg/s) 27,91361,716 210,40761,626
Tau w (msec) 12.761.7 10.060.4
Arterial Pressure
Systolic (mmHg) 138.369.7 151.465.0
Diastolic (mmHg) 91.265.9 90.966.9
MAP (mmHg) 108.766.6 113.764.7
Parameters: heart rate (HR), end systolic pressure (ESp), end diastolic pressure
(EDp), cardiac output (CO), stroke volume (SV), the positive and negative
derivatives of pressure development (+dP/dt and 2dP/dt, respectively), and LV
pressure Tau (Tau w). Hypoxia values were derived at 5 minutes into the
challenge. Arterial pressure values were derived by conductance catheterization
in the right carotid artery. All values are expressed as mean6s.e.m.
*P,0.05.
HCR, high capacity runner (Baseline: n=11, Dobutamine: n=8, Esmolol: n=4,
Hypoxia: n=7), LCR, low capacity runner (Baseline: n=9, Dobutamine: n=8,
Esmolol: n=4, Hypoxia: n=5).
doi:10.1371/journal.pone.0006117.t003
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c). The sarcomere length shortening amplitude was not different
between groups. As discussed in detail below, these results suggest
that altered calcium handling may underlie susceptibility to
cardiac contractile dysfunction in rats with low aerobic running
capacity.
Analysis of cardiac protein expression in LCR and HCR
rats
Based on functional differences in sarcomere shortening and
calcium transient kinetics, we sought to determine whether
subcellular alterations in protein expression between LCR and
HCR rats could explain these findings. Myocardial protein
expression analysis showed that LCR rats had significantly greater
amounts of b – myosin heavy chain (MHC) compared to HCR
rats (Figure 7a and b). Previous studies have shown that the a-
MHC isoform (the dominant isoform in rodent hearts) is a fast
motor protein compared to the beta isoform [24]. Slight
alterations in the stoichiometry of these MHC isoforms can
dramatically affect cardiac function [24]. In combination with
alterations in calcium handling (Figure 6), the finding that LCR
rats had increased expression of b-MHC is consistent with isolated
cell data showing slower kinetics of myocyte contractility. b-MHC
is a common indicator of upregulation of the fetal gene program
associated with heart failure [25]. To address whether this gene
program was activated in LCR hearts we analyzed other markers
of the fetal gene program (e.g. transcript levels of b-MHC, BNP,
and a-skeletal actin analyzed by qRT-PCR). There were no
differences in the relative abundance of transcripts for these
markers in LCR hearts compared to HCR hearts (Table S1).
Thyroid hormone signaling is also associated with MHC
isoform changes [26,27]. Thus, thyroid hormones were analyzed
in LCR and HCR animals to assess whether this variable may be
contributing to the observed changes in MHC isoform in LCR rats
(Table 4). There were no differences in measures of serum T4, free
T4, serum T3, or free T3. However, animals with low intrinsic
aerobic capacity had significantly increased levels of thyroid
stimulating hormone consistent with a state of pre-clinical
hypothyroidism[28] (TSH: LCR, 2.260.2 vs. HCR,
0.760.2 ulU/mL; P,0.05). Although these data are consistent
with a depressed metabolic state in LCR animals stimulating
compensatory thyroid production of TSH, these thyroid hormone
results indicate that the MHC isoform switch is not the
consequence of altered thyroid hormone levels.
Western blot analysis of key calcium handling proteins including
the sarco-endoplasmic reticulum ATPase (SERCA2a), phospho-
lamban, the sarcolemal sodium-calcium exchanger, and calse-
questrin showed no differences between LCR and HCR rats
(Figure S1). To address baseline adrenergic tone that directly
affects contractility and calcium handling in myocytes at the
molecular level, Western blot detection was performed for tandem
serine 23/24 phosphorylation on troponin I as well as serine 16
phosphorylation of phospholamban. This analysis again revealed
no difference between LCR and HCR cohorts (Figure S1).
Figure 4. Analysis of cardiac function during acute exposure to hypoxia. (a) Representative raw traces of LV pressure at baseline and during
the time course of exposure to hypoxia showing development of intractable irregular contractions in LCR rats and progressive diminution in pump
function in HCR rats. (b) Survival graph showing cumulative mortality across a 50 minute acute hypoxic challenge. HCR, high capacity runner (n=7);
LCR, low capacity runner (n=5).
doi:10.1371/journal.pone.0006117.g004
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From the cellular to whole organ level, this study provides new
insight into the cardiac performance of animals artificially
selected for inherent aerobic running capacity. At generation 19
of artificial selection, divergence in intrinsic aerobic capacity as
measured by run time to exhaustion was significant, with a 436%
difference between high capacity runners (HCR) and low
capacity runners (LCR). Analysis of baseline cardiac function
by echocardiography and catheter-based conductance microma-
nometry revealed minor differences in whole animal cardiovas-
cular performance. However, in support of previous evidence
showing deficiencies in oxygen transport and oxidative metabo-
lism in LCR rats, our findings reveal significant differences
between LCR and HCR rats in cardiac response to a
pathophysiological challenge. Animals with low inherent aerobic
capacity were highly susceptible to reduced oxygen availability as
evidenced by increased susceptibility to hypoxia induced
contractile dysfunction compared to animals with high intrinsic
aerobic capacity. In vitro analysis of isolated myocytes revealed
slower kinetics of calcium cycling and contractility. Furthermore,
this study provides the first evidence to our knowledge that
artificial selection for aerobic capacity (with no inciting injury
such as myocardial infarction or pressure overload) results in
increased expression of b-MHC protein in animals with
intrinsically low aerobic capacity. Together these findings provide
new insights into the underlying cardiovascular deficiencies
associated with metabolic syndrome.
Figure 5. Analysis of cardiac irregular contractions during acute exposure to hypoxia. (a) Representative graphical presentations of
fluctuations in the periodicity of the pressure waveform, defined as irregular ventricular contractions (see Methods) between LCR rats (left) and HCR
rats (right) during the time course of exposure to hypoxia. (b) Average number of irregular contractions within a given segment of 500 beats among
LCR and HCR rats at baseline and during hypoxia. 2 Way ANOVA analysis of the data showed a statistically higher number of irregular ventricular
contractions in LCR vs. HCR rats (P,0.05). (c) Survival graph showing cumulative mortality due exclusively to intractable irregular contractions across
a 50 minute acute hypoxic challenge. HCR, high capacity runner (n=7); LCR, low capacity runner (n=5).
doi:10.1371/journal.pone.0006117.g005
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PLoS ONE | www.plosone.org 8 July 2009 | Volume 4 | Issue 7 | e6117Figure 6. Calcium and contractility kinetics of acutely isolated myocytes. Representative raw traces of (a) calcium transients (vertical
bar=0.05 360/380 ratio, horizontal bar=0.25 seconds) and (b) sarcomere length shortening kinetics (vertical bar=0.05 um, horizontal bar=0.25
seconds) from acutely isolated cardiac myocytes derived from LCR (dotted line) and HCR (solid line) rats. Raw transient traces (left) and normalized
transients (right). (c) Mean summarized data showing sarcomere length shortening kinetics and (d) calcium transient kinetics from LCR and HCR rats
(n=45 myocytes/group). LCR, low capacity runner; HCR, high capacity runner. Values are expressed as mean6SEM. *P,0.05.
doi:10.1371/journal.pone.0006117.g006
Figure 7. Western blot analysis of b-MHC protein. (a) Representative Western blot of beta myosin heavy chain (b-MHC) protein levels in low
and high capacity rats. (b) Summarized mean data showing differences in protein abundance based on densitometric quantitation. Values are
expressed as mean6SEM. *P,0.05. n=6–9/group. LCR, low capacity runner; HCR, high capacity runner.
doi:10.1371/journal.pone.0006117.g007
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aerobic capacity
Increased expression of b-MHC in the heart has consistently
been reported to occur in the failing heart or in response to various
pathophysiological challenges [25,29,30]. In this study we showed
that b-MHC protein is increased in animals with low intrinsic
aerobic capacity. To our knowledge, this is the first study to show
that this MHC isoform switching in the heart occurs in response to
selection for intrinsic aerobic capacity. Furthermore, no evidence
of overt heart failure was seen nor intervention of an inciting
stimulus (such as exercise training, myocardial infarction, or
pressure overload) was used in this study. This is evidence that the
MHC isoform switching occurs as a result of segregation of cardiac
risk factors based on artificial selection separating low and high
aerobic capacity animals.
The increase in b-MHC protein was not corroborated at the
mRNA level based on qRT-PCR analysis. A similar discordance
between b-MHC protein and mRNA has been demonstrated to
occur in the pathologic heart [25,30]. For example, Delcayre and
colleagues have shown that after seven days of pressure overload
induced by aortic constriction, b-MHC protein was increased
from 5% to 31% of total MHC without any changes in mRNA.
Numerous other studies have shown that, in the absence of
changes in mRNA, regulation of MHC protein is highly
dependent on a wide range of stimuli [25,30,31,32]. Evidence
from this study suggests that a novel stimulus for MHC isoform
switching in the adult heart is genetic segregation of factors
associated with low intrinsic aerobic capacity.
The implications of this MHC isoform switch reveal funda-
mental physiological differences between low and high aerobic
capacity animals. Specifically, the b-MHC isoform is a slow motor
protein that is more economical in its ATPase activity compared to
the a-MHC isoform [33]. Prior studies showing a shift in
metabolic substrate usage[13] and VO2max measurements
[14,15,16,23] between LCR and HCR animals are consistent
with a molecular transition to this more economical MHC isoform
in rats with intrinsically low aerobic capacity. Despite the energetic
benefits, contractile function is markedly compromised when b-
MHC is increased in the heart [24,34]. Furthermore, studies have
shown that increased expression of b-MHC in an a-MHC
dominant mouse heart causes negative cardiac remodeling in
response to numerous stresses (e.g. increases in systolic and
diastolic LV dimensions) [35]. These findings are consistent with
our observation that LCR hearts have increased geometric
dimensions and SV at baseline which may reflect a compensatory
remodeling response to this increased b-MHC in the heart.
However, the negative inotropic effects of increased b-MHC
expression in LCR hearts are not as evident. During the acute
hypoxic challenge, we propose that pathologic alterations
associated with changes in calcium handling cause the emergence
of irregular contractions prior to the manifestation of systolic
pump failure attributable to MHC isoform switching.
LCR hearts have increased susceptibility to irregular
pump function during hypoxia
Hemodynamic function of LCR and HCR rats was measured
during extended exposure to a controlled state of hypoxia. This
acute hypoxic challenge specifically targets the critical aspects of
cardiac function regarding oxidative metabolism. The results of
this study reveal an increased susceptibility to hypoxia in LCR rats
consistent with the finding that risk factors for cardiac disease and,
specifically, deficiencies in cardiac calcium homeostasis segregate
with aerobic running capacity. Furthermore, this study shows that
the primary cause of cardiac failure for LCR rats during exposure
to hypoxia was the development of fatal intractable irregular
contractions. We hypothesize that the mechanistic basis for this
cardiac contractile irregularity during episodes of energetic crisis in
LCR rats is multifactorial.
First, based on previous evidence showing differences in
metabolic substrate usage between LCR and HCR rats [13], this
susceptibility to hypoxia in LCR rats could be due to deficiencies
in native oxidative metabolic function. Specifically, previous
findings have shown reduced VO2max [14,15,16,23] and shift
from lipid metabolism to carbohydrate metabolism[13] in rats
selectively bread for low aerobic running capacity. This metabolic
shift in LCR hearts would significantly increase the damage caused
by fatty acid toxicity during hypoxia. The consequences of this
physiological state are poignantly revealed by the development of
fatal intractable irregular contractions in LCR rats during episodes
of cardiac energetic crisis as seen in this study. Secondly, this study
provides mechanistic data supporting a role for MHC isoform
switching and altered calcium handling as a basis for the observed
susceptibility to pump dysfunction in LCR rats. Overall, the results
of this study provide new and important insights into the role of
altered calcium homeostasis in the development of cardiac
contractile dysfunction during hypoxia and energetic insufficiency.
A role for altered calcium handling accounting for
contractile dysfunction
A role for altered calcium handling has been strongly associated
with conduction (e.g. early or delayed after depolarizations) and
non-conduction (e.g. calcium induced after contractions) related
contractile dysfunction [36,37,38]. Thus, decreased calcium
cycling coupled with delayed calcium decay during diastole are
implicated in cardiac contractile failure [37,39]. This is consistent
with the observations in this study as shown in myocytes isolated
from LCR animals. Previously, alterations in calcium cycling have
been attributed to proteins critically involved in tightly regulating
calcium homeostasis in the myocytes [36]. However, this study
revealed no difference in the expression level of these proteins nor
in the phosphorylation status of phospholamban, which is involved
in regulating calcium cycling through SERCA2a [40].
Previous studies have found that LCR rats have reduced
expression of key mitochondrial enzymes required for energy
substrate metabolism [12]. In this study it was hypothesized that
impairment of mitochondrial function may link reduced fitness to
cardiovascular and metabolic disease [12]. In support of this, we
speculate that mitochondrial dysfunction and thus decreased
availability of ATP that occurs during hypoxia likely exacerbates
the dysfunction of SERCA2a-dependent calcium re-sequestration
Table 4. Thyroid Hormone Analysis.
HCR LCR
Serum T4 (ug/dL) 2.6460.16 2.9260.16
Free T4 (ng/dL) 1.7560.04 1.7760.05
Serum T3 (ng/dL) 58.1862.93 56.7462.58
Free T3 (pg/dL) 2.9160.07 2.8560.06
TSH (ulU/mL) 0.7460.16 2.1760.17*
All values are expressed as mean6s.e.m.
*P,0.05 for LCR vs. HCR.
Terms: T4, Thyroxine; T3, Triiodothyronine. TSH, thyroid stimulating hormone.
HCR, high capacity runner (n=8–32), LCR, low capacity runner (n=8–32).
doi:10.1371/journal.pone.0006117.t004
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observed increase in susceptibility to irregular contractile dysfunc-
tion during this challenge.
Studies of calcium cycling implicate calcium leak through the
ryanodine receptor (RyR) due to increased RyR open probability
(Po) as contributing to heart failure-related dysfunction [41,42].
However, Dibb et al and Venetucci et al report that increased
RyR Po in the context of reduced SR calcium is not sufficient to
induce sustained arrhythmogenic calcium release events [37,43].
Only in the context of a correlative increase in pPLN (required to
reach some threshold level of SR calcium storage) is increased
RyR Po likely to be problematic. The current study shows that
LCR rats have significantly lower calcium transients, which
suggests that this mechanism is also not contributing to the
observed contractile dysfunction in LCR rats during hypoxia. In
light of the current data set, we propose that a non-canonical
mechanism (perhaps associated with metabolic dysfunction) is
implicated in altering the calcium regulation in LCR myocytes
thus giving rise to the contractile dysfunction observed in these
hearts.
Conclusion
This study provides insights into the relationship between
metabolic syndrome and cardiac function. These data reveal for
the first time that selection for low intrinsic aerobic capacity is
sufficient to drive changes in MHC isoform composition in the
adult heart. Furthermore, low aerobic capacity hearts are highly
susceptible to irregular ventricular contractions during an acute
hypoxic challenge. Thus, in addition to common therapeutic
efforts to ameliorate cardiac energy demands during stress by use
of beta-blockers, it has been suggested that immediate intervention
at the level of metabolic control (decrease myocardial fatty acid
oxidation and increase glucose oxidation) may also be critically
important for the stabilization of patients with acute cardiac injury
[44,45,46]. Lastly, recent studies of LCR and HCR animals has
shown that high intensity aerobic interval training (85–90% of
maximal oxygen uptake (VO2max)) resulted in significant correc-
tion of the metabolic syndrome phenotype in LCR animals [47].
In addition to the regulation of metabolic control during acute
injury, exercise training is also a clinically relevant mechanism for
ameliorating pathologies associated with metabolic syndrome.
Recognizing the interaction between gene and environment, this
study reveals that polygenic traits associated with risk factors for
cardiovascular disease co-segregate with low aerobic fitness.
Supporting Information
Figure S1 Western blot analysis. (a) Representative Western
blots of proteins including serine 23,24 phosphorylation of cardiac
troponin I (pTnI), the sarco-endoplasmic reticulum ATPase
(SERCA2a), phospholamban (PLN), phospho-phospholamban
(pPLN), the sarcollemal sodium-calcium exchanger (NCX), and
calsequestrin (CSQ). (b) Summarized mean data for each protein
based on densitometric quantitation. Values are expressed as
mean6SEM. n=6–9/group. LCR, low capacity runner; HCR,
high capacity runner.
Found at: doi:10.1371/journal.pone.0006117.s001 (0.76 MB JPG)
Table S1 All values are expressed as mean6s.e.m. All values are
normalized to ribosomal 18s RNA. HCR, high capacity runner;
LCR, low capacity runner. N=16–24/group
Found at: doi:10.1371/journal.pone.0006117.s002 (0.01 MB
DOC)
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